Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Asia-Pacific Alpha-Glucosidase Inhibitors Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)
... had a statistically greater incidence of type 2 diabetes and other kinds of diabetes in the Asia-Pacific region. Individuals with no history of diabetes who recovered from SARS-CoV-2 infections have been reported to develop insulin ... Read More
-
EUROPE DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... pandemic has substantially impacted the European Diabetes Drugs Market. People with diabetes have a weak immune system so, with COVID-19, the immune system gets weaker very fast. People with diabetes have more chances to get ... Read More
-
UNITED STATES DIABETES DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The average number of new COVID-19 cases ... Read More
-
Asia-Pacific Insulin Pens Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... market is estimated to reach a value of more than USD 19 billion by 2027. The COVID-19 pandemic positively impacted the Asia-Pacific Insulin Pens Market. Patients with diabetes, infected with COVID-19 may experience elevated blood ... Read More
-
ITALY DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Italy was the first country in Europe affected by COVID-19. Italy is among the countries with ... Read More
-
Saudi Arabia Diabetes Care Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period (2022-2027). In Riyadh, hospitalized COVID-19 patients had a significant frequency of diabetes mellitus. Even though people with diabetes have a higher mortality rate than people without the disease, other factors, including advanced age, congestive ... Read More
-
RUSSIA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Russia has the ninth-highest number of confirmed cases in the world affected by COVID-19. Most people ... Read More
-
SOUTH AFRICA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 380 million by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Africa. Patients with diabetes, infected with ... Read More
-
COMBINATION ANTI-DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... market is estimated to reach a value of more than USD 8 billion by 2027. Diabetes mellitus increases the risk of viral infections, especially during the period of poor glycemic control. Emerging evidence suggests that ... Read More
-
PHILIPPINES DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... COVID-19 is a novel sickness caused by a SARS-CoV-2 virus strain. The great majority of people infected with the virus will develop mild to moderate respiratory illness and recover without requiring special treatment. The aged ... Read More
-
SPAIN DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... According to WHO, 102,258,825 vaccination doses have been delivered as of June 25, 2022. Regardless of past diabetes history, entrance hyperglycemia is a significant predictor of all-cause mortality in COVID-19 patients who are not severely ... Read More
-
FRANCE DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in diabetes mellitus, such as advanced ... Read More
-
MEXICO DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people who have died of COVID-19 were affected by the co-occurrence of two or more ... Read More
-
VIETNAM DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... effectively stopped transmission of the COVID-19 outbreak since the outset, with no deaths for months. Since then, however, the fourth wave of the COVID-19 outbreak has wreaked devastation on Vietnam. According to the Ministry of ... Read More
-
SOUTH KOREA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 1 billion by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Korea. Patients with diabetes, infected with ... Read More
-
EGYPT DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... market is estimated to reach a value of more than USD 730 million by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in Egypt. Patients with diabetes, infected with COVID-19 may experience ... Read More
-
GERMANY INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... over the forecast period. One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in ... Read More
-
North America Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period, 2022-2027. In North America, diabetes incidence for Type-2 diabetes and other diabetes forms was numerically higher in individuals with COVID-19. Insulin resistance and impaired insulin secretion have been described in individuals without diabetes history ... Read More
-
North America Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2022-2027. In North America, till April 2022, the United States is having the highest COVID cases with 82 million, the country also registered the highest death rate. According to the Diabetes Voice article published in ... Read More
-
LATIN AMERICA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The COVID-19 pandemic has been testing the capacity to respond and adapt to populations, governments, and health systems worldwide. In the Latin America region, Brazil presented the first suspected and the first confirmed cases ... Read More
-
Asia-Pacific Biguanide Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... estimated to reach a value of more than USD 2 billion by 2027. The COVID-19 pandemic positively impacted the Asia-Pacific Biguanide Market. According to a study by BeatO in 2021 on 800 people, patients with ... Read More
-
EGYPT DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period (2022-2027). The market is estimated to reach a value of more than USD 430 million by 2027. The COVID-19 pandemic positively impacted the Egypt diabetes care devices market growth. Patients with diabetes, infected with ... Read More
-
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 7 molecules. Out of which approximately 2 molecules are developed by companies and remaining by the universities/institutes. The latest ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Diabetic Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy, a common complication of diabetes, is damage to the nerves that allow feeling things such as pain. Symptoms include tingling, numbness, burning ... Read More
Research Assistance
